MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$143.98
−1.35%Forward multiples
Based on analyst estimates
- P/E forward
- 16.68x
- P/E 2026E
- 54.76x
- P/E 2027E
- 15.67x
- P/E 2028E
- 14.18x
- P/S forward
- 5.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- 114.27x
- PEG TTM
- 0.20x
- Price / book
- 8.47x
- Price / sales
- 5.35x
- Price / cash flow
- 17.79x
Enterprise value
- Enterprise value
- $402.0B
- EV / sales
- 6.05x
- EV / EBITDA
- 28.87x
- EV / EBIT
- 36.36x
- Market cap
- $355.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026